A phase II trial of paricalcitol in myelodysplastic syndromes
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2018
At a glance
- Drugs Paricalcitol (Primary)
- Indications Leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 25 Jan 2018 Status changed from active, no longer recruiting to completed.
- 16 Oct 2005 New trial record.